Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway
In conclusion, our study reveals TXNIP as a promising new predictive marker and therapeutic target for pancreatic cancer.PMID:38229544 | DOI:10.3724/abbs.2023286
Source: Acta Biochimica et Biophysica Sinica - Category: Biochemistry Authors: Qinglin Fei Kaizhou Jin Saimeng Shi Tianjiao Li Duancheng Guo Mengxiong Lin Xianjun Yu Weiding Wu Longyun Ye Source Type: research
More News: Biochemistry | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Lung Cancer | Men | Pancreas | Pancreatic Cancer | Study | Thyroid | Thyroid Cancer